Cargando…
Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function
Inhibition of complement factor 5 (C5) reduced myocardial infarction in animal studies, while no benefit was found in clinical studies. Due to lack of cross-reactivity of clinically used C5 antibodies, different inhibitors were used in animal and clinical studies. Coversin (Ornithodoros moubata comp...
Autores principales: | Pischke, Soeren E., Gustavsen, A., Orrem, H. L., Egge, K. H., Courivaud, F., Fontenelle, H., Despont, A., Bongoni, A. K., Rieben, R., Tønnessen, T. I., Nunn, M. A., Scott, H., Skulstad, H., Barratt-Due, A., Mollnes, T. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336537/ https://www.ncbi.nlm.nih.gov/pubmed/28258298 http://dx.doi.org/10.1007/s00395-017-0610-9 |
Ejemplares similares
-
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016) -
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
por: Orrem, Hilde L., et al.
Publicado: (2018) -
The Role of Complement in Liver Injury, Regeneration, and Transplantation
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2019) -
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017) -
Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis
por: Skjeflo, Espen W., et al.
Publicado: (2015)